{5 (dienogest 2 MG / estradiol valerate 2 MG Oral Tablet) / 17 (dienogest 3 MG / estradiol... — RxCUI 978949
RxNorm drug concept · Generic pack
RxCUI 978949
Generic pack · GPCK
● Current RxNorm concept 2 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI978949
Official name{5 (dienogest 2 MG / estradiol valerate 2 MG Oral Tablet) / 17 (dienogest 3 MG / estradiol valerate 2 MG Oral Tablet) / 2 (estradiol valerate 1 MG Oral Tablet) / 2 (estradiol valerate 3 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asDienogest-Estra val 2 MG (5) Oral Tablet / Dienogest-Estra val 2 MG (17) Oral Tablet / Estra val 1 MG (2) Oral Tablet / Estra val 3 MG (2) Oral Tablet / Inert 1 MG (2) Oral Tablet 28 Day Pack
FDA products mapped2
Package NDCs mapped5
Reported Medicaid activity (SDUD)4,257 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Estradiol Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's designed to ease the moderate to severe hot flashes and night sweats that come with menopause. When estrogen levels drop after menopause, your body's hormonal signals go a bit...
- What exactly is this medication supposed to do for me?
- Apply it to your upper thigh — alternating right and left sides each day — and spread it over an area roughly the size of two palm prints. Let it dry completely before getting dres...
- How do I use the gel correctly so it actually works?
🕸️ Concept Web — How {5 (dienogest 2 MG / estradiol valerate 2 MG Ora... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{5 (dienogest 2 MG / estradiol valerate 2 MG Oral Tablet) / 17 (dienogest 3 MG / estradiol valerate 2 MG Oral Tablet) / 2 (estradiol valerate 1 MG Oral Tablet) / 2 (estradiol valerate 3 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack
RxCUI 978949 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Dienogest
22968IN -
Estradiol
4083IN -
Inert ingredients
748794IN -
Dienogest / estradiol
994203MIN -
Estradiol valerate
24395PIN
-
Dienogest
-
Dose forms 18
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dienogest / estradiol Oral Tablet
978943SCDF -
Estradiol Oral Tablet
372078SCDF -
Inert ingredients Oral Tablet
748796SCDF -
Dienogest / estradiol valerate Oral Tablet
2646918SCDFP -
Estradiol valerate Oral Tablet
2648917SCDFP -
Dienogest / estradiol Oral Product
1158329SCDG -
Dienogest / estradiol Pill
1158330SCDG -
Estradiol Oral Product
1165185SCDG - +10 more in this family
-
Dienogest / estradiol Oral Tablet
-
Clinical & branded drugs 11
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dienogest 2 MG / estradiol valerate 2 MG Oral Tablet
978944SCD -
Dienogest 3 MG / estradiol valerate 2 MG Oral Tablet
978946SCD -
Estradiol valerate 1 MG Oral Tablet
978948SCD -
Estradiol valerate 3 MG Oral Tablet
978941SCD -
Inert ingredients 1 MG Oral Tablet
748797SCD -
Dienogest 2 MG
438962SCDC -
Dienogest 3 MG
978945SCDC -
Estradiol valerate 1 MG
978947SCDC - +3 more in this family
-
Dienogest 2 MG / estradiol valerate 2 MG Oral Tablet
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 22 of 35 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dienogest 2 MG / estradiol valerate 2 MG Oral Tablet
SCD · 978944 -
Dienogest 3 MG / estradiol valerate 2 MG Oral Tablet
SCD · 978946 -
Estradiol valerate 1 MG Oral Tablet
SCD · 978948 -
Estradiol valerate 3 MG Oral Tablet
SCD · 978941 -
Inert ingredients 1 MG Oral Tablet
SCD · 748797 -
Dienogest 2 MG
SCDC · 438962 -
Dienogest 3 MG
SCDC · 978945 -
Estradiol valerate 1 MG
SCDC · 978947 -
Estradiol valerate 2 MG
SCDC · 978942 -
Estradiol valerate 3 MG
SCDC · 978940
Brand-Name Concepts
📦 FDA Products & Package NDCs
2 products · 5 package NDCs
5 package NDCs map to RxCUI 978949 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-4110-15 | 3 BLISTER PACK in 1 PACKAGE (0781-4110-15) / 1 KIT in 1 BLI... | Estradiol Valerate and Estradiol Valerate/Dienogest | Sandoz Inc | 2020-01-21 |
| 50419-0409-00 | 90 BLISTER PACK in 1 PACKAGE (50419-409-00) / 1 KIT in 1 BL... | Natazia | Bayer HealthCare Pharmaceuticals Inc. | 2010-05-06 |
| 50419-0409-03 | 3 BLISTER PACK in 1 PACKAGE (50419-409-03) / 1 KIT in 1 BLI... | Natazia | Bayer HealthCare Pharmaceuticals Inc. | 2010-05-06 |
| 50419-0409-73 | 5 BLISTER PACK in 1 PACKAGE (50419-409-73) / 1 KIT in 1 BLI... | Natazia | Bayer HealthCare Pharmaceuticals Inc. | 2010-05-06 |
| 50419-0409-76 | 2 BLISTER PACK in 1 PACKAGE (50419-409-76) / 1 KIT in 1 BLI... | Natazia | Bayer HealthCare Pharmaceuticals Inc. | 2010-05-06 |
Observed labelers:
Bayer HealthCare Pharmaceuticals Inc. (4) ·
Sandoz Inc (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.